MVision not only provides unique AI-powered solutions for Radiotherapy treatment planning but also follows the highest standards of data protection for clinics and their patients. This is of utmost importance…
The generation of synthetic images has greatly advanced in recent years due to the progress of artificial intelligence. Some of the applications have recently been widely popularized in media, especially…
S Warren, N Richmond MVision AI software has been under evaluation at NCCC (Newcastle upon Tyne Hospitals NHS Foundation Trust) since 28 February 2022* in order to: 1. compare AI…
2022 came to an end. Seeing our names of customers, the number of scans and countries marked on the map, we know, we reached our accomplishments for 2022, because of…
Finland, Helsinki, December 14, 2022 – MVision AI, the leading provider of AI-powered Guideline Based Segmentation solution for Radiotherapy planning and Tecnosan, advanced healthcare technology for radiotherapy and medical physics…
Diese Woche konzentrieren wir uns auf Forschungsergebnisse, die während der Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) vorgestellt wurden. Vier Studien konzentrierten sich auf die richtlinienbasierte Segmentierungslösung GBS™ von MVision…
ESTRO2020 is up and running and so are our special ESTRO2020 web demo sessions! To celebrate the last full day of the scientific program, we want to make the sessions…
What is MVision and how are we changing the face of cancer treatment? Check out the video with our founder and CEO Mahmudul Hasan and Dr. Heikki Minn from Turku University…
The holiday season is a time of recharging, reflecting, and often also reading. Since our hearts pump for improving radiotherapy with AI throughout the year, our holiday readings also include…
We are happy to announce the publication of our first peer-reviewed paper. The retrospective multicenter study proves that using a general deep learning-based automated segmentation tool for CT images indeed…